2[1]Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care[ J]. Am J Hosp Pharm, 1990( 1 ) ,47:533. 被引量：1
3[2]Anonymous. Draft statement on pharmaceutical care[J]. Am J Hosp Pharm,1993,50(1) :126 ～8. 被引量：1
4[3]Traulsen JM, Klinke BO. Using health technology assessment to put pharmaceutical care on the political agenda[ J]. Pharm World Sci,2004,26(2) :61. 被引量：1
5[4]Lazarou J, Pomeranz BH, Corey PN. Incidence of ADR in hospitalized patients[J]. JAMA, 1997,279 ( 13 ): 1200. 被引量：1
6[5]McElnay J. Getting pharmaceutical care into community practice[J]. Pharm J,1998,261:570. 被引量：1
7[7]Miyazaki N, Sekine Y, Aoyama T, et al. Development and evaluation of pharmaceutical services in the ICU/CCU by medical staffs[J]. Yakugaku Zasshi ,2004,124(5 ) :279. 被引量：1
8[9]Balen RM, Jewesson PJ. Pharmacist computer skills and needs assessment survey[ J]. J Med Internet Res,2004,6( 1 ) :e11. 被引量：1
9[12]Foroni LA, Rochat MH,Trouiller P, et al. Particle contamination in a ternary nutritional admixture[J]. J Parenter Sci Thchnol, 1993,47(6) :311. 被引量：1
10[13]Paoletti QD, Casey EW. Reducing costs through centralization and standardization of an iv admixtures program[J]. Am J Health Syst Pharm ,2000 ,57 (12) :114. 被引量：1
